Online citations, reference lists, and bibliographies.
← Back to Search

Polymer Therapeutics: Concepts And Applications.

R. Haag, F. Kratz
Published 2006 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Polymer therapeutics encompass polymer-protein conjugates, drug-polymer conjugates, and supramolecular drug-delivery systems. Numerous polymer-protein conjugates with improved stability and pharmacokinetic properties have been developed, for example, by anchoring enzymes or biologically relevant proteins to polyethylene glycol components (PEGylation). Several polymer-protein conjugates have received market approval, for example the PEGylated form of adenosine deaminase. Coupling low-molecular-weight anticancer drugs to high-molecular-weight polymers through a cleavable linker is an effective method for improving the therapeutic index of clinically established agents, and the first candidates have been evaluated in clinical trials, including, N-(2-hydroxypropyl)methacrylamide conjugates of doxorubicin, camptothecin, paclitaxel, and platinum(II) complexes. Another class of polymer therapeutics are drug-delivery systems based on well-defined multivalent and dendritic polymers. These include polyanionic polymers for the inhibition of virus attachment, polycationic complexes with DNA or RNA (polyplexes), and dendritic core-shell architectures for the encapsulation of drugs. In this Review an overview of polymer therapeutics is presented with a focus on concepts and examples that characterize the salient features of the drug-delivery systems.
This paper references
10.1038/nm1002
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
R. Satchi-Fainaro (2004)
10.1016/S0169-409X(03)00108-X
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.
P. Caliceti (2003)
10.1038/38444
Crystal structure of the nucleosome core particle at 2.8 Å resolution
K. Luger (1997)
10.1002/(SICI)1521-3773(20000403)39:7<1285::AID-ANIE1285>3.0.CO;2-F
The Localization of Guests in Water-Soluble Oligoethyleneoxy-Modified Poly(propylene imine) Dendrimers This work was supported by the Netherlands Foundation for Chemical Research (CW), with financial aid from the Netherlands Organisation for Scientific Research (NWO). The authors thank Stefan Mesker
Baars (2000)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates
P. Vasey (1999)
Polymer Therapeutics Angewandte Chemie
R. Langer (1998)
10.1021/BC049814L
Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel.
T. Ooya (2004)
Heparin and modified heparin inhibit complement activation in vivo.
J. Weiler (1992)
10.1007/BF00731288
Will complex carbohydrate ligands of vascular selectins be the next generation of non-steroidal anti-inflammatory drugs?
Winkelhake Jl (1991)
10.1074/jbc.M308643200
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
10.1054/bjoc.2001.2026
PDEPT: polymer-directed enzyme prodrug therapy
R. Satchi (2001)
10.1016/S0168-3659(01)00309-1
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.
H. Maeda (2001)
10.1016/S0959-437X(00)00164-7
Drug-targeting strategies in cancer therapy.
P. Huang (2001)
10.1021/BC020041F
pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrier.
M. Jones (2003)
10.1016/S0168-3659(01)00328-5
Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
R. Duncan (2001)
10.1038/nbt995
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
S. Shaunak (2004)
10.1021/CR940351U
Polymeric systems for controlled drug release.
K. Uhrich (1999)
10.1021/JA992648L
Design, Synthesis, and Characterization of a High-Affinity Trivalent System Derived from Vancomycin and l-Lys-d-Ala-d-Ala
J. Rao (2000)
10.1002/1097-0215(20010601)92:5<718::AID-IJC1257>3.0.CO;2-D
Pre‐clinical evaluation of a methotrexate–albumin conjugate (MTX‐HSA) in human tumor xenografts in vivo
A. Burger (2001)
10.1093/RHEUMATOLOGY/41.10.1133
Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial.
E. Choy (2002)
10.1002/1521-3773(20021115)41:22<4252::AID-ANIE4252>3.0.CO;2-F
pH-responsive molecular nanocarriers based on dendritic core-shell architectures.
M. Kraemer (2002)
10.1002/ANIE.200330071
Hermann Staudinger and the future of polymer research jubilees-beloved occasions for cultural piety.
H. Ringsdorf (2004)
10.1021/JM9905864
A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy.
F. Kratz (2000)
10.1021/BC034044J
Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system.
H. Tuerk (2004)
10.1038/sj.bjc.6600516
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
N. Schoemaker (2002)
10.1016/S0959-8049(99)00030-1
HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
E. Gianasi (1999)
10.1201/9780849348129.CH1
N-(2-Hydroxypropyl) methacrylamide Copolymer Conjugates
R. Duncan (2005)
10.1021/CM047825I
Photosensitization of Singlet Oxygen via Two-Photon-Excited Fluorescence Resonance Energy Transfer in a Water-Soluble Dendrimer
Michael A. Oar (2005)
10.1021/BC020056D
Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs.
N. Murthy (2003)
10.1097/00001813-200104000-00003
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel
J. M. Meerum Terwogt (2001)
10.1007/978-3-540-38918-7_5140
[Anticancer drugs].
H. Fujita (1995)
Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
P. Loadman (1999)
10.1158/1078-0432.CCR-03-0746
A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
J. Rademaker-Lakhai (2004)
10.1016/S0168-3659(01)00320-0
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.
B. Říhová (2001)
10.1038/nature03794
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Shiladitya Sengupta (2005)
10.1021/JA960461D
Self-Assembled Monolayers of Alkanethiolates Presenting Tri(propylene sulfoxide) Groups Resist the Adsorption of Protein
L. Deng (1996)
10.1211/0022357011776612
New strategies for polymer development in pharmaceutical science — a short review
A. Godwin (2001)
10.1021/BK-1993-0520.CH002
Polymeric Drug Delivery Systems: An Overview
P. Sinko (1993)
Oncol
L. W. Seymour (1676)
10.1016/S0378-5173(98)00378-0
Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA.
S. Richardson (1999)
10.1517/13543784.9.3.497
Soluble cytokine receptors: novel immunotherapeutic agents
R. Fernández-Botrán (2000)
10.1021/BC9600630
In vitro gene delivery by degraded polyamidoamine dendrimers.
M. X. Tang (1996)
10.1002/ANGE.19901020204
Starburst‐Dendrimere: Kontrolle von Größe, Gestalt, Oberflächenchemie, Topologie und Flexibilität beim Übergang von Atomen zu makroskopischer Materie
D. Tomalia (1990)
10.1016/0927-7765(94)80007-3
Block copolymer micelles as vehicles for hydrophobic drugs
G. Kwon (1994)
10.1016/J.CCR.2005.02.007
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.
Ronit Satchi-Fainaro (2005)
10.1002/0471578908
Synthetic Multivalent Molecules
Seok-ki Choi (2004)
Riebeseel in Polymeric Biomaterials, 2nd ed
F. Kratz (2001)
10.1002/ANIE.198103051
Polymeric Antitumor Agents on a Molecular and on a Cellular Level
L. Gros (1981)
10.1378/CHEST.119.1_SUPPL.64S
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
J. Hirsh (2001)
10.1073/PNAS.92.16.7297
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
O. Boussif (1995)
10.1002/(SICI)1521-3765(19990503)5:5<1440::AID-CHEM1440>3.0.CO;2-M
Poly(propyleneimine) Dendrimers as pH‐Sensitive Controlled‐Release Systems
G. Pistolis (1999)
Tumoritropic and lymphotropic principles of macromolecular drugs.
H. Maeda (1989)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1021/JA963874N
Synthesis of New α-Thiosialodendrimers and Their Binding Properties to the Sialic Acid Specific Lectin from Limax flavus
D. Zanini (1997)
10.1021/BC00023A012
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture.
J. Hänsler (1993)
10.1073/PNAS.93.10.4897
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers.
J. Kukowska-Latallo (1996)
10.1002/ANIE.200351962
Self-immolative dendrimers.
R. Amir (2003)
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
G. Hartung (1999)
10.1002/ANGE.200300640
Ein synthetisches Antithrombin III bindendes Pentasaccharid ist jetzt ein Wirkstoff! Was kommt danach?
M. Petitou (2004)
10.1016/B978-0-12-060310-7.50010-9
Polymeric Drug Delivery Systems
S. Kim (1980)
10.1016/S1389-0352(01)00066-6
Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers.
Jörg Dennig (2002)
10.1002/cbic.200300905
Dendritic Polyamines: Simple Access to New Materials with Defined Treelike Structures for Application in Nonviral Gene Delivery
M. Kraemer (2004)
10.1016/S1074-5521(99)80047-7
Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
J. Rao (1999)
10.1055/S-2002-34309
The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
M. Petitou (2002)
10.1021/JM020276C
Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound.
F. Kratz (2002)
10.1002/(SICI)1521-3757(19981016)110:20<2908::AID-ANGE2908>3.0.CO;2-2
Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren
M. Mammen (1998)
10.1093/NAR/GNH140
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
R. Schiffelers (2004)
10.1615/CRITREVTHERDRUGCARRIERSYST.V16.I3.10
Drug-polymer conjugates containing acid-cleavable bonds.
F. Kratz (1999)
10.1586/14737140.3.6.823
Evolving role of pegylated interferons in metastatic renal cell carcinoma
T. Choueiri (2003)
10.1002/ANIE.200250284
Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery.
Derk Joester (2003)
Technology evaluation: PK1, Pfizer/Cancer Research UK.
V. Bilim (2003)
10.1021/BM010032U
Partial synthetic glucan sulfates as potential new antithrombotics: a review.
S. Alban (2001)
10.1093/JAC/DKH156
Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria.
A. King (2004)
Pharmacol
A. Godwin (1184)
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.
Ahmed M. Mansour (2003)
10.3892/IJO.11.3.497
Enhanced albumin uptake by rat tumors.
A. Wunder (1997)
10.1002/POLC.5070510111
Structure and properties of pharmacologically active polymers
H. Ringsdorf (2007)
10.1016/S0959-440X(96)80037-6
Syntheses and some applications of chemically defined multivalent glycoconjugates.
R. Roy (1996)
Delivery Targeting Proteins
D. Fischer (2005)
10.1097/00001813-200304000-00002
Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients
G. Molineux (2003)
10.1038/256495a0
Continuous cultures of fused cells secreting antibody of predefined specificity
G. Köhler (1975)
10.1021/JA00120A032
The dendritic box, shape-selective liberation of encapsulated guests
J. Jansen (1995)
10.1002/ANIE.199001381
Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter
D. Tomalia (1990)
10.1007/0-306-47932-X_1
Challenges in polymer therapeutics: state of the art and prospects of polymer drugs.
A. Kabanov (2003)
10.1016/S0168-3659(01)00323-6
Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
J. Singer (2001)
10.1007/BF00047468
Transport of molecules across tumor vasculature
R. Jain (2004)
10.1021/BC0256289
Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy.
A. Warnecke (2003)
10.1016/S0093-7754(03)00314-2
Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia.
J. Crawford (2003)
10.1016/S0169-409X(02)00017-0
Block copolymer micelles for delivery of gene and related compounds.
Y. Kakizawa (2002)
10.1111/j.1476-5381.1994.tb16187.x
Infection by HIV‐1 blocked by binding of dextrin 2‐sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T‐cells
S. Shaunak (1994)
10.1021/LA990829V
Quaternized Poly(propylene imine) Dendrimers as Novel pH-Sensitive Controlled-Release Systems
Z. Sideratou (2000)
10.1007/0-306-47932-X_6
Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data.
J. Singer (2003)
10.1002/1521-3757(20021115)114:22<4426::AID-ANGE4426>3.0.CO;2-1
pH‐spaltbare molekulare Nanotransporter auf der Basis dendritischer Kern‐Schale‐Architekturen
M. Kraemer (2002)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1200/JCO.20.6.1668
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
L. Seymour (2002)
10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
M. Mammen (1998)
10.1615/CRITREVTHERDRUGCARRIERSYST.V17.I2.20
Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review.
R. Greenwald (2000)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
Chem
F. Kratz (1256)
10.1200/JCO.2003.03.143
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.
E. Rowinsky (2003)
10.1016/S1359-0286(97)80125-8
Polymers and proteins: interactions at interfaces
I. Szleifer (1997)
10.1002/ANGE.19810930405
Polymere Antitumormittel auf molekularer und zellulärer Basis
L. Gros (1981)
10.5555/URI:PII:002221439390147Q
Sulfated polysaccharides in inflammation.
K. Arfors (1993)
10.1002/ANIE.200461603
Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy.
W. Jang (2005)
10.1002/ANGE.200301694
Supramolekulare Wirkstoff‐Transportsysteme auf der Basis polymerer Kern‐Schale‐Architekturen
R. Haag (2004)
Heparin, non-heparin glycosaminoglycans, and heparinoids: an overview of their application in atherosclerosis.
H. Engelberg (1991)
10.1016/S0168-3659(01)00341-8
Development of the polymer micelle carrier system for doxorubicin.
T. Nakanishi (2001)
10.1200/JCO.2004.12.043
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
P. Sabbatini (2004)
10.1586/14787210.1.3.423
Peginterferon-α2a(40 kDa)/ribavirin combination for the treatment of chronic hepatitis C infection
W. Vogel (2003)
10.2174/1568009023333836
Cancer-targeted polymeric drugs.
Y. Luo (2002)
10.1016/S0163-7258(99)00018-2
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs.
G. Dubowchik (1999)
10.1038/nrd1088
The dawning era of polymer therapeutics
R. Duncan (2003)
10.1016/S0968-0896(98)00005-4
Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity.
R. Greenwald (1998)
10.1016/0924-2244(93)90085-O
Carbohydrates and carbohydrate polymers: edited by Manssur Yalpani, ATL press, 1993. $180.00 (v + 314 pages) ISBN 1 882360 40 0
J. N. Bemiller (1993)
Drug delivery and targeting.
R. Langer (1998)
10.1021/MA025617A
Design of biocompatible dendrimers with environment sensitivity
Chie Kojima (2003)
10.1021/BC020091K
PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
R. Satchi-Fainaro (2003)
Toida in Carbohydrates in Drug Design (Eds.
T.R.J. Linhardt (1997)
10.1002/ANIE.200461657
Single-triggered trimeric prodrugs.
Keren Haba (2005)
10.2165/00003088-200342130-00002
Macromolecular Therapeutics
K. Greish (2003)
Acid pH in tumors and its potential for therapeutic exploitation.
I. Tannock (1989)
10.1080/1061186021000051062
Targeting Tumor Vasculature: Reality or a Dream?
R. Satchi-Fainaro (2002)
10.1021/JM00021A007
Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition.
M. Mammen (1995)
10.1007/3-540-46577-4_3
Host-Guest Chemistry of Dendritic Molecules
M. Baars (2000)
10.1126/SCIENCE.280.5364.708
A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.
J. Rao (1998)
10.1016/0959-8049(94)00514-6
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.
L. Seymour (1995)
10.1002/ANGE.200330071
Hermann Staudinger und die Zukunft der Polymerforschung Jubiläumsfeiern – selbstbestimmter Anlass kultureller Frömmigkeit
H. Ringsdorf (2004)
Carbohydrates and Carbohydrate Polymers
E. DeClercq (1993)
10.1016/0168-3659(93)90172-2
Block copolymer micelles as vehicles for drug delivery
Kataoka Kazunori (1993)
10.1016/J.ADDR.2003.10.040
Polymeric anticancer drugs with pH-controlled activation.
K. Ulbrich (2004)
10.1016/S1074-5521(96)90285-9
Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups.
S. K. Choi (1996)
10.1016/J.JCONREL.2003.09.013
An overview of current delivery systems in cancer gene therapy.
Anas El-Aneed (2004)
10.2174/1573413052953110
Nanosystems in Drug Targeting: Opportunities and Challenges
Jaspreet K. Vasir (2005)
10.1055/S-2003-41635
Pegylation of interferon alfa: structural and pharmacokinetic properties.
S. Pedder (2003)
10.1016/J.ADDR.2005.09.019
Dendrimer biocompatibility and toxicity.
R. Duncan (2005)
10.2174/1389201033489711
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
B. Říhová (2003)
Transport of molecules in the tumor interstitium: a review.
R. Jain (1987)
10.1002/ANIE.200301694
Supramolecular drug-delivery systems based on polymeric core-shell architectures.
R. Haag (2004)
10.1002/ANIE.200300640
A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
M. Petitou (2004)
Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.
E. Auzenne (2002)
10.1021/BC990036K
DNA complexing with polyamidoamine dendrimers: implications for transfection.
A. Bielinska (1999)
10.1038/35001095
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
P. Kitov (2000)
10.1055/S-0037-1615131
Heparin and cancer.
L. Zacharski (1998)
10.1021/JA963519X
Generation and in Situ Evaluation of Libraries of Poly(acrylic acid) Presenting Sialosides as Side Chains as Polyvalent Inhibitors of Influenza-Mediated Hemagglutination
Seok-ki Choi (1997)
10.1021/JA994363E
An Approach to Glycerol Dendrimers and Pseudo-Dendritic Polyglycerols
R. Haag (2000)
10.1021/BC0000583
Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs.
C. Kojima (2000)
10.1016/S0939-6411(00)00075-8
HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action.
J. Kopeček (2000)
10.1016/S0169-409X(00)00124-1
Block copolymer micelles for drug delivery: design, characterization and biological significance.
K. Kataoka (2001)
10.1080/1061186021000072456
HPMA Copolymers Platinates Containing Dicarboxylato Ligands. Preparation, Characterisation and In Vitro and In Vivo Evaluation
E. Gianasi (2002)
10.1038/nbt0802-768
The “grand” problem of synthetic delivery
J. Wolff (2002)
10.1002/ANIE.200250653
Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change.
Y. Bae (2003)
10.1016/S0731-7085(99)00315-5
Determination of MAG-camptothecin, a new polymer-bound camptothecin derivative, and free camptothecin in dog plasma by HPLC with fluorimetric detection.
D. Fraier (2000)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1177/026765910101600512
Heparin-coated cardiopulmonary bypass circuits: current status
L. C. Hsu (2001)
10.1021/BC034160M
Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes.
C. Brus (2004)



This paper is referenced by
10.2217/nnm.10.71
Polymer-drug conjugates for novel molecular targets.
J. Sanchis (2010)
10.1517/17425247.5.5.593
Polymer conjugates as therapeutics: future trends, challenges and opportunities
M. J. Vicent (2008)
10.2147/IJN.S140073
Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
Y. Jun (2017)
10.1002/ANIE.200701776
Encapsulation of myoglobin in PEGylated polyion complex vesicles made from a pair of oppositely charged block ionomers: a physiologically available oxygen carrier.
A. Kishimura (2007)
10.1039/b919329d
Real-time monitoring of drug release.
Roy Weinstain (2010)
10.1021/MA2008018
Postpolymerization Modification of Hydroxyl-Functionalized Polymers with Isocyanates
F. Biedermann (2011)
Zastosowanie nanonośników w medycynie
Justyna Siemieniec (2013)
10.1007/s13233-013-1047-0
In vitro evaluation of the thermosensitive and magnetic nanoparticles for the controlled drug delivery of vitamin D3
Yi-Hsin Lien (2013)
10.1021/ol800932w
Synthesis of fluorogenic polymers for visualizing cellular internalization.
Shane L Mangold (2008)
10.1016/J.POLYMER.2008.06.009
Chemo-enzymatic synthesis and sustained release of optically active polymeric prodrugs of chlorphenesin
J. Quan (2008)
10.1002/chem.200800892
A convergent approach to biocompatible polyglycerol "click" dendrons for the synthesis of modular core-shell architectures and their transport behavior.
M. Wyszogrodzka (2008)
10.1002/9781119188896.CH6
Functional Materials and Applied Systems
B. Voit (2016)
10.1016/J.CHEMBIOL.2007.07.007
Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers.
J. L. de Paz (2007)
Exploring nanosystems for biomedical applications focusing on photodynamic therapy and drug delivery
V. Kirejev (2014)
10.1002/chem.201702942
A pH‐sensitive Macromolecular Prodrug as TLR7/8 Targeting Immune Response Modifier
S. Aichhorn (2017)
10.1055/S-0036-1591847
Synthesis of Asparagusic Acid Modified Lysine and its Application in Solid-Phase Synthesis of Peptides with Enhanced Cellular Uptake
Alina Tirla (2017)
10.1002/ejic.201801077
Stimuli‐Responsive Phosphorus‐Based Polymers
I. Teasdale (2019)
10.1016/j.addr.2017.06.002
Covalent nano delivery systems for selective imaging and treatment of brain tumors.
J. Ljubimova (2017)
10.1039/C4RA10407B
Synthesis and encapsulation of an amphiphilic thermoresponsive star polymer with β-cyclodextrin and hyperbranched poly(oligo(ethylene glycol)methacrylate) as building blocks
Yinwen Li (2014)
10.1039/C3PY01566A
Core-cross-linked micellar nanoparticles from a linear-dendritic prodrug for dual-responsive drug delivery
Y. Zhang (2014)
10.1039/C4PY00430B
Structure related transport properties and cellular uptake of hyperbranched polyglycerol sulfates with hydrophobic cores
F. Paulus (2014)
10.1016/J.POLYMER.2012.08.053
Stimuli-responsive microgels for the loading and release of functional compounds: Fundamental concepts and applications
Daniel Klinger (2012)
10.1002/marc.200900166
Kinetics of Complex Formation between DNA and Cationically Charged Cylindrical Brush Polymers Observed by Stopped Flow Light Scattering.
F. Kuehn (2009)
10.1002/mabi.201200344
Synthesis of maleimide-functionalyzed HPMA-copolymers and in vitro characterization of the aRAGE- and human immunoglobulin (huIgG)-polymer conjugates.
Kristof Tappertzhofen (2013)
10.1021/bm400410e
Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth.
Ahmad Fawzi Hussain (2013)
10.1158/1535-7163.MCT-09-1076
Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
S. Chae (2010)
10.2174/156802608785848969
Preface. Polymer science and polymer therapeutics: macromolecules, dendrimers and nanomedicine.
M. Micha-Screttas (2008)
10.1016/j.bmcl.2010.02.035
Tuning the pH sensitivities of orthoester based compounds for drug delivery applications by simple chemical modification.
Hélène Bruyère (2010)
10.1016/J.DRUDIS.2006.07.011
The development of molecular clamps as drugs.
S. T. Weiss (2006)
10.1016/j.ijpharm.2014.09.053
Prolonged local retention of subcutaneously injected polymers monitored by noninvasive SPECT imaging.
Chie Kojima (2014)
10.1039/c5sm00824g
pH-Responsive assembly of metal nanoparticles and fluorescent dyes by diblock copolymer micelles.
H. Kim (2015)
10.1002/POLA.26594
Tandem dynamic kinetic resolution and enzymatic polycondensation to synthesize mPEG-functionalized poly(amine-co-ester)-type chiral prodrugs
Xueqi Qian (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar